Predictive value of ‘Smartscopy’ for the detection of preinvasive cervical lesions during the COVID-19 pandemic: a diagnostic study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: To evaluate the performance of "Smartscopy" in diagnosing preinvasive cervical lesions among patients with abnormal cervical cancer screening results obtained during the coronavirus disease 2019 (COVID-19) pandemic. Methods: This diagnostic study enrolled non-pregnant women with abnormal cervical cancer screening results obtained at the colposcopy clinic at Srinagarind Hospital (Khon Kaen, Thailand) between September 2020 and March 2021. Two colposcopists independently evaluated the uterine cervix using a smartphone and colposcopy. Cervical biopsies and endocervical curettage were performed in accordance with standard procedures. The diagnostic performance of a smartphone in detecting low-grade squamous intraepithelial lesions or worse plus (LSIL+) and high-grade squamous intraepithelial lesions plus (HSIL+) was assessed. Results: In total, 247 patients were included. There was high agreement between the two colposcopists (κ=0.88; 95% confidence interval [CI], 0.82-0.93). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the smartphone to detect LSIL+ were 96.6% (95% CI, 91.6-99.1), 12.9% (95% CI, 8.06-19.2), 46.2% (95% CI, 39.7-52.4), 83.3% (95% CI, 62.6-95.3), and 0.49% (95% CI, 0.43-0.55), respectively. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of smartscopy in diagnosing HSIL+ were 67.6% (95% CI, 55.2- 78.5), 85.4% (95% CI, 79.9-90.0), 60.5% (95% CI, 48.6-71.6), 88.9% (95% CI, 83.7-92.9), and 81.0% (95% CI, 0.75-0.85), respectively. Conclusion: Smartscopy demonstrated a remarkable correlation with colposcopy and a high diagnostic performance value for the detection of preinvasive cervical lesions. Therefore, smartscopy may be an alternative tool for detecting abnormal cervical lesions in low to medium medical resource settings. Smartscopy may be applied in telemedicine during the COVID-19 pandemic.
Abstract
Objective: To evaluate the performance of "Smartscopy" in diagnosing preinvasive cervical lesions among patients with abnormal cervical cancer screening results obtained during the coronavirus disease 2019 (COVID-19) pandemic. Methods: This diagnostic study enrolled non-pregnant women with abnormal cervical cancer screening results obtained at the colposcopy clinic at Srinagarind Hospital (Khon Kaen, Thailand) between September 2020 and March 2021. Two colposcopists independently evaluated the uterine cervix using a smartphone and colposcopy. Cervical biopsies and endocervical curettage were performed in accordance with standard procedures. The diagnostic performance of a smartphone in detecting low-grade squamous intraepithelial lesions or worse plus (LSIL+) and high-grade squamous intraepithelial lesions plus (HSIL+) was assessed. Results: In total, 247 patients were included. There was high agreement between the two colposcopists (κ=0.88; 95% confidence interval [CI], 0.82-0.93). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the smartphone to detect LSIL+ were 96.6% (95% CI, 91.6-99.1), 12.9% (95% CI, 8.06-19.2), 46.2% (95% CI, 39.7-52.4), 83.3% (95% CI, 62.6-95.3), and 0.49% (95% CI, 0.43-0.55), respectively. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of smartscopy in diagnosing HSIL+ were 67.6% (95% CI, 55.2- 78.5), 85.4% (95% CI, 79.9-90.0), 60.5% (95% CI, 48.6-71.6), 88.9% (95% CI, 83.7-92.9), and 81.0% (95% CI, 0.75-0.85), respectively. Conclusion: Smartscopy demonstrated a remarkable correlation with colposcopy and a high diagnostic performance value for the detection of preinvasive cervical lesions. Therefore, smartscopy may be an alternative tool for detecting abnormal cervical lesions in low to medium medical resource settings. Smartscopy may be applied in telemedicine during the COVID-19 pandemic.
참고문헌 (23)
- Arbyn M, "Estimates of incidence and mortality of cervical cancer in 2018 : a worldwide analysis", Lancet Glob Health, 8, pp.191~203 (2020)
- Gaffney DK, "Too many women are dying from cervix cancer : problems and solutions", Gynecol Oncol, 151, pp.547~554 (2018)
- Chrysostomou AC, "Methodologies of primary HPV testing currently applied for cervical cancer screening", Life(Basel), 10, pp.290~ (2020)
- Chen W, "Cancer statistics in China, 2015", CA Cancer J Clin, 66, pp.115~132 (2016)
- Bhatla N, "Primary HPV screening for cervical cancer", Best Pract Res Clin Obstet Gynaecol, 65, pp.98~108 (2020)
- Cholli P, "Screening for cervical cancer among HIVpositive and HIV-negative women in cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography : findings of initial screening and one-year follow-up", Gynecol Oncol, 148, pp.118~125 (2018)
- Mungo C, "Scaling up cervical cancer prevention in Western Kenya : treatment access following a community-based HPV testing approach", Int J Gynaecol Obstet, 152, pp.60~67 (2021)
- Khan MJ, "ASCCP colposcopy standards : role of colposcopy, benefits, potential harms, and terminology for colposcopic practice", J Low Genit Tract Dis, 21, pp.223~229 (2017)
- Barut MU, "Analysis of sensitivity, specificity, and positive and negative predictive values of smear and colposcopy in diagnosis of premalignant and malignant cervical lesions", Med Sci Monit, 21, pp.3860~3867 (2015)
- 남계현, "Colposcopy at a turning point", Obstetrics & Gynecology Science, 61(1), pp.1~6 (2018), 대한산부인과학회[DOI]
- Gallay C, "Cervical cancer screening in low-resource settings : a smartphone image application as an alternative to colposcopy", Int J Womens Health, 9, pp.455~461 (2017)
- Melbye S, "Smartphone-based self-monitoring, treatment, and automatically generated data in children, adolescents, and young adults with psychiatric disorders : systematic review", JMIR Ment Health, 7, pp.e17453~ (2020)
- Bokolo Anthony Jnr, "Use of telemedicine and virtual care for remote treatment in response to COVID-19 pandemic", J Med Syst, 44, pp.132~ (2020)
- Tanaka Y, "Histologic correlation between smartphone and coloposcopic findings in patients with abnormal cervical cytology : experiences in a tertiary referral hospital", Am J Obstet Gynecol, 221, pp.241.e1~241.e6 (2019)
- Catarino R, "Smartphone use for cervical cancer screening in lowresource countries : a pilot study conducted in madagascar", PLoS One, 10, pp.e0134309~ (2015)
- Tran PL, "Performance of smartphone-based digital images for cervical cancer screening in a low-resource context", Int J Technol Assess Health Care, 34, pp.337~342 (2018)
- Nayar R, "The pap test and bethesda 2014", Cancer Cytopathol, 123, pp.271~281 (2015)
- Bornstein J, "2011 colposcopic terminology of the international federation for cervical pathology and colposcopy", Obstet Gynecol, 120, pp.166~172 (2012)
- Perkins RB, "2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors", J Low Genit Tract Dis, 24, pp.102~131 (2020)
- Bomfim-Hyppólito S, "Cervicography as an adjunctive test to visual inspection with acetic acid in cervical cancer detection screening", Int J Gynaecol Obstet, 92, pp.58~63 (2006)
- 김수녕, "Development and validation of novel digitalized cervicography system", Obstetrics & Gynecology Science, 59(3), pp.227~232 (2016), 대한산부인과학회[DOI]
- Singhakum N, "Digital cervicography by simply portable device as an alternative test for cervical cancer screening in rural area of Thailand", Asian Pac J Cancer Prev, 19, pp.1145~1149 (2018)
- Sato M, "A pilot study of mobile digital colposcopy in Japanese patients with cervical intraepithelial neoplasm", Mol Clin Oncol, 15, pp.207~ (2021)